Recent Circulars
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revised schedule for offer to buy acquisition window (takeover) of SANMITRA COMMERCIAL LIMITED shares from January 6-20, 2026 at Rs. 15.00 … | |||||||||||||||
Revised schedule for offer to buy acquisition window (takeover) of SANMITRA COMMERCIAL LIMITED shares from January 6-20, 2026 at Rs. 15.00 per share for up to 1,49,76,000 equity shares.
| |||||||||||||||
Revised schedule for the acquisition window (takeover) offer for SANMITRA COMMERCIAL LIMITED, extending from January 6-20, 2026, with offer … | |||||||||||||||
Revised schedule for the acquisition window (takeover) offer for SANMITRA COMMERCIAL LIMITED, extending from January 6-20, 2026, with offer price of Rs. 15.00 per share for up to 1,49,76,000 equity shares.
| |||||||||||||||
Revised schedule of activities for the acquisition window (takeover) of shares of Sanmitra Commercial Limited, scheduled from January 6, … | |||||||||||||||
Revised schedule of activities for the acquisition window (takeover) of shares of Sanmitra Commercial Limited, scheduled from January 6, 2026 to January 20, 2026.
| |||||||||||||||
Revised schedule for the acquisition window (takeover) of SANMITRA COMMERCIAL LIMITED equity shares from January 6, 2026 to January 20, 2026 … | |||||||||||||||
Revised schedule for the acquisition window (takeover) of SANMITRA COMMERCIAL LIMITED equity shares from January 6, 2026 to January 20, 2026 at an offer price of Rs. 15.00 per share.
| |||||||||||||||
Revised schedule of activities for the Offer to Buy – Acquisition Window (Takeover) of SANMITRA COMMERCIAL LIMITED shares, running from … | |||||||||||||||
Revised schedule of activities for the Offer to Buy – Acquisition Window (Takeover) of SANMITRA COMMERCIAL LIMITED shares, running from January 6, 2026 to January 20, 2026.
| |||||||||||||||
High Court of Judicature at Bombay Official Liquidator Report regarding Biowin Pharma (India) Ltd. and multiple other companies in … | |||||||||||||||
High Court of Judicature at Bombay Official Liquidator Report regarding Biowin Pharma (India) Ltd. and multiple other companies in liquidation proceedings.
| |||||||||||||||
SEBI final order under sections 11 and 11B of SEBI Act 1992 against Ashish S Parekh and 12 other entities for front running trades of a big … | |||||||||||||||
SEBI final order under sections 11 and 11B of SEBI Act 1992 against Ashish S Parekh and 12 other entities for front running trades of a big client.
| |||||||||||||||
SEBI final order under Sections 11 and 11B of SEBI Act, 1992 in the matter of front running by Ashish S Parekh and 12 other connected … | |||||||||||||||
SEBI final order under Sections 11 and 11B of SEBI Act, 1992 in the matter of front running by Ashish S Parekh and 12 other connected entities involving trades of a big client.
| |||||||||||||||
SEBI final order under Sections 11 and 11B of SEBI Act against 13 entities including Ashish S Parekh for front running trades of a big … | |||||||||||||||
SEBI final order under Sections 11 and 11B of SEBI Act against 13 entities including Ashish S Parekh for front running trades of a big client (Paresh N Bhagat).
| |||||||||||||||
SEBI final order under Sections 11 and 11B of SEBI Act, 1992 in the matter of front running by Ashish S Parekh and 12 other connected … | |||||||||||||||
SEBI final order under Sections 11 and 11B of SEBI Act, 1992 in the matter of front running by Ashish S Parekh and 12 other connected entities involved in fraudulent trading activities.
| |||||||||||||||